Cardiovascular Dysfunction in Polycystic Ovary Syndrome: Mitochondrial and Inflammatory Mechanisms
BioMed Research International · 2026
DOI: 10.1155/bmri/1110229 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift BioMed Research International, 2026. Verfasst von Olabimpe Caroline Badejogbin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, School of Basic Medical Sciences, Babcock University, Ilishan-Remo, Ogun State, Nigeria, babcock.edu.ng. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Cardiovascular Diseases, Inflammation, Mitochondria. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Polycystic ovary syndrome (PCOS) is a common endocrine disorder that significantly increases cardiovascular disease (CVD) risk in women. While insulin resistance and dyslipidemia are established contributors, growing evidence highlights mitochondrial dysfunction and chronic low‐grade inflammation as central drivers of cardiovascular pathology in PCOS.
Objective
This narrative review synthesizes current evidence on how mitochondrial dysfunction and inflammation interact to promote cardiovascular complications in women with PCOS while identifying potential therapeutic targets and areas requiring further investigation.
Methods
A comprehensive review of clinical and experimental studies was conducted using PubMed, Scopus, and Web of Science databases. Relevant literature exploring mitochondrial alterations, oxidative stress, inflammatory cytokines, and endothelial function in PCOS, with emphasis on cardiovascular outcomes, was critically evaluated and summarized.
Results
Women with PCOS exhibit altered mitochondrial dynamics, reduced ATP production, and elevated reactive oxygen species (ROS), which collectively impair vascular function. These mitochondrial abnormalities compromise oocyte quality and endometrial receptivity and activate proinflammatory signaling pathways, including the NLRP3 inflammasome, contributing to endothelial dysfunction and atherogenesis, and increased long‐term cardiovascular risk, particularly in women with prior pregnancy complications. Elevated levels of cytokines including TNF‐ α , IL‐6, and CRP further exacerbate cardiovascular risk. This bidirectional relationship between mitochondrial dysfunction and inflammation establishes a vicious cycle underlying cardiovascular deterioration in PCOS.
Conclusion
Mitochondrial dysfunction and inflammation are interdependent mechanisms that contribute substantially to cardiovascular risk in women with PCOS. Targeting mitochondrial dysfunction and systemic inflammation presents a promising therapeutic strategy for reducing cardiovascular morbidity in PCOS. Future research should emphasize phenotype‐specific interventions, biomarker discovery, and translational trials to improve long‐term reproductive and cardiovascular outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, School of Basic Medical Sciences, Babcock University, Ilishan-Remo, Ogun State, Nigeria, babcock.edu.ng.
- Department of Physiology, Kampala International University, Western Campus, Ishaka, Uganda, kiu.ac.ug.
- Department of Physiology, Alex Ekwueme Federal University, Ebonyi State, Nigeria.
- Department of Medical Physiology, University of Rwanda, Huye, Rwanda, ur.ac.rw.
- Department of Physiology, College of Medicine, Olabisi Onabanjo University, Ago-Iwoye, Ogun State, Nigeria, oouagoiwoye.edu.ng.
- Department of Physiology, Faculty of Basic Medical Sciences, College of Medicine, Achievers University, Owo, Ondo State, Nigeria, medcol.mw.
ORCID-Profile: Olabimpe Caroline Badejogbin, Mary Olaoluwa Agunloye, Makinde Vincent Olubiyi, Olaniyi Azeez Soetan
Zitieren
APA
Badejogbin, O. C., Agunloye, M. O., Chijioke-Agu, O. E., Olubiyi, M. V., Olugbuyiro, S. O., Soetan, O. A., Bamgbose, O. A., & Olaleye, T. O. (2026). Cardiovascular Dysfunction in Polycystic Ovary Syndrome: Mitochondrial and Inflammatory Mechanisms. BioMed Research International. https://doi.org/10.1155/bmri/1110229
Vancouver
Badejogbin OC, Agunloye MO, Chijioke-Agu OE, Olubiyi MV, Olugbuyiro SO, Soetan OA, et al. Cardiovascular Dysfunction in Polycystic Ovary Syndrome: Mitochondrial and Inflammatory Mechanisms. BioMed Research International. 2026. doi:10.1155/bmri/1110229
BibTeX
@article{Badejogbin2026,
author = {Badejogbin, Olabimpe Caroline and Agunloye, Mary Olaoluwa and Chijioke-Agu, Ojichukwuka Ebere and Olubiyi, Makinde Vincent and Olugbuyiro, Success Oluwanifesimi and Soetan, Olaniyi Azeez and Bamgbose, Opeyemi Abel and Olaleye, Tobi Opeyemi},
title = {Cardiovascular Dysfunction in Polycystic Ovary Syndrome: Mitochondrial and Inflammatory Mechanisms},
journal = {BioMed Research International},
year = {2026},
doi = {10.1155/bmri/1110229}
}
EUVIMED